Login   |  Users Online: 1635 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size
Search Article 
  
Advanced search 
   Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts
RESEARCH ARTICLE
Year : 2009  |  Volume : 30  |  Issue : 3  |  Page : 337-341

A clinical study to evaluate the efficacy of Pippali Rasayana in certain respiratory disorders


1 Lecturer in Kayachikitsa, Himalayiya Ayurvedic Medical College, Shyampur, Dehradun, India
2 Professor & Principal, P.G. Dept. of Kayachikitsa, R.G. Govt. P. G. Ayurveda College, Paprola (Himachal Pradesh), India
3 Professor, P. G. Dept. of Kayachikitsa, Rajiv Gandhi Government Post Graduate Ayurveda College, Paprola (Himachal Pradesh), India

Correspondence Address:
Deepti Bisht
Lecturer in Kayachikitsa, Himalayiya Ayurvedic Medical College, Shyampur, Dehradun
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


Rights and PermissionsRights and Permissions

Two million people die per year due to pulmonary tuberculosis all over the world. The 15 million new cases are diagnosed every year in India, of which 90% have pulmonary tuberculosis. Chronic bronchitis is the second most common lung disorder after pulmonary tuberculosis equally prevalent in rural and urban areas. Similarly nearly 6% population suffers from Bronchial asthma in India. Respiratory system is one such in human body which gets affected from a variety of infections and condition may become worse when body lacks sufficient immunity. Though drugs like corticosteroids, bronchodilators, anti tubercular therapy offer relief but may have many side effects. In Ayurveda answer to these problems is Rasayana therapy. Role of Rasayana therapy with recent advancement can be adjusted in terms of immuno modulatory, cytoprotective, genoprotective, adaptogenic, stress reliever actions etc. In this study a textual formulation. 'Pippali Rasayana' was given for a period of 45 days after Koshtha shodhana to 15 patients diagnosed with common respiratory diseases. Control group of 12 patients was observed as such while taking their respective medications. A remarkable improvement was noted in clinical features as well as general conditions of these patients indicating the beneficial role of 'Pippali Rasayana' as adjuvant.


[PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1421    
    Printed80    
    Emailed0    
    PDF Downloaded511    
    Comments [Add]    

Recommend this journal